Why Nigerian Healthtech Startups Struggle to Survive After Seed Funding
Published 7 July 2026
Healthtech funding in Nigeria fell more than 67% from its 2023 peak. Here is why the money dried up, and which startups are built to survive the contraction.
The Money Has Slowed, But the Problems Have Not
Nigeria's healthtech sector tells a story familiar to anyone who has watched a hype cycle play out in technology before: an exciting surge driven by genuine urgency, followed by a much harder reckoning once that urgency fades. According to the State of Healthtech in Nigeria 2026 report, investment into the sector peaked at nearly $55 million in 2023, then fell by more than 67% to roughly $18 million in 2024, and continued sliding to around $3 to 4 million in 2025. For founders who built their companies during the boom years, this contraction has forced an uncomfortable but necessary reckoning with what their businesses actually need to survive.
Why the Funding Surge Happened in the First Place
The pandemic created a rare alignment of urgent need and investor appetite. Patients suddenly needed remote consultations and medicine delivery in ways they had not before, and investors saw a clear, visible problem that digital health companies appeared positioned to solve. This drove funding from roughly $5.5 million in 2019 up to nearly $47.32 million in 2021, continuing to climb toward its 2023 peak.
That surge brought real benefits. It funded the launch and early growth of dozens of startups across telehealth, e-pharmacy, healthcare analytics, and digital financing. It is part of why Nigeria's healthtech ecosystem added 65 new startups between 2020 and 2025, more startups than the entire 15 years before the pandemic combined.
Why the Money Dried Up
Funding tends to follow urgency, and once lockdowns ended and physical healthcare access resumed, the acute crisis that had made digital health an obvious investment thesis softened considerably. Investors who had moved quickly during the pandemic began asking harder questions about unit economics, retention, and whether Nigerian healthtech business models could actually scale profitably in a market where insurance penetration remains low and most healthcare spending is still paid out of pocket.
Abiodun Adereni, founder of HelpMum, summarised the shift many founders experienced: a widely shared belief that pandemic-era digital health adoption would simply continue, followed by the harder reality that, as physical movement resumed, startups had to prove sustainability beyond the urgency that originally created their market.
What Survives a Funding Contraction Like This
Not every healthtech company responds to a funding downturn the same way. Companies with genuine recurring revenue, rather than those reliant entirely on pandemic-driven one-time usage spikes, tend to weather contractions better. Startups that built around solving a persistent structural problem, such as fragmented medical supply chains or chronic disease management, have an inherent advantage over those that solved a temporary pandemic-specific need, since the underlying demand for the former does not disappear once lockdowns end.
Partnerships also matter more during lean funding periods. Startups that built integrations with hospitals, HMOs, and existing healthcare infrastructure, rather than operating as standalone consumer apps competing purely for downloads, tend to have more durable revenue streams that are less dependent on continuous new venture funding to survive.
What This Means for Patients Choosing Health Apps Today
A funding contraction across an entire sector inevitably means some companies will shut down, get acquired, or significantly scale back operations. If you have been using a particular health app or platform, it is reasonable to occasionally check whether the company is still actively operating and maintaining its services, particularly if you depend on it for something important like medication reminders, chronic disease tracking, or scheduled telemedicine consultations.
This is one advantage of choosing platforms with verified ties to established, accredited healthcare infrastructure rather than standalone apps with no underlying institutional backing. Medicall's verified healthcare directory connects you directly to real hospitals and clinics, giving you a foundation that does not depend on a single startup's funding runway.
Find verified hospitals and clinics near you on Medicall.
Frequently Asked Questions
How much has healthtech funding in Nigeria declined since its peak?
Funding peaked at nearly $55 million in 2023, then fell by more than 67% to approximately $18 million in 2024, and continued declining to around $3 to 4 million in 2025, according to the State of Healthtech in Nigeria 2026 report.
Why did Nigerian healthtech funding decline so sharply?
Once pandemic-era urgency faded and physical healthcare access resumed, investors began asking harder questions about unit economics and long-term sustainability in a market with low insurance penetration and high out-of-pocket healthcare spending.
What kinds of healthtech startups are surviving the funding contraction?
Startups with genuine recurring revenue, those solving persistent structural problems rather than temporary pandemic-specific needs, and those with integrations into existing hospital and HMO infrastructure tend to be more resilient during funding downturns.
Should I worry about a health app I use shutting down?
It is reasonable to periodically check whether a health app or platform you rely on is still actively operating, particularly during a sector-wide funding contraction, especially if you depend on it for something important like medication reminders or scheduled care.
How can I choose a healthtech platform that is less likely to disappear?
Favour platforms with verified ties to established, accredited healthcare infrastructure rather than standalone consumer apps with no institutional backing, since these tend to be more durable regardless of broader funding trends.